Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nissle 1917 Safety in Healthy Volunteers
NCT02276508Phase 1Completed
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of escherichia coli nissle 1917 in urinary tract infection (UTI). Primary endpoint: Number of adverse events associated with ingestion of E. coli Nissle 1917 at 30 days. Started Oct 2014; status: completed.
02
Drugs
escherichia coli nissle 1917
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02276508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276508.